Results 121 to 130 of about 61,552 (282)
Effects of clozapine on cerebral catecholaminergic neurone systems [PDF]
G. Bartholini+4 more
openalex +1 more source
Review of withdrawal catatonia: what does this reveal about clozapine?
Withdrawal symptoms are common upon discontinuation of psychiatric medications. Catatonia, a neuropsychiatric condition proposed to be associated with gamma-aminobutyric acid (GABA) hypoactivity due to its robust response to benzodiazepines, has been ...
M. Lander, T. Bastiampillai, J. Sareen
semanticscholar +1 more source
A common action of clozapine, haloperidol, and remoxipride on D1- and D2-dopaminergic receptors in the primate cerebral cortex. [PDF]
Michael S. Lidow+1 more
openalex +1 more source
Clozapine is associated with secondary antibody deficiency
Background Schizophrenia affects 1% of the population. Clozapine is the only medication licensed for treatment-resistant schizophrenia and is intensively monitored to prevent harm from neutropenia.
Mark J. Ponsford+13 more
semanticscholar +1 more source
Clozapine: progress in treating refractory schizophrenia. [PDF]
S.R. Hirsch, Basant K. Puri
openalex +1 more source
d‐amino acids: new functional insights
This review explores recent advances in understanding d‐amino acids (d‐AAs) and their pivotal roles across organisms, from plants to humans. d‐AAs have been implicated in key physiological processes, including cancer, inflammation, immune regulation, kidney disease, diabetes, and nervous system function.
Loredano Pollegioni+5 more
wiley +1 more source
Inflammatory response to clozapine in the absence of myocarditis: case report
A case is presented of a 25-year-old man with treatment-resistant paranoid schizophrenia whose only previous trial of clozapine had been stopped following a suspected clozapine-induced myocarditis.
Patrick Davey+2 more
doaj +1 more source
Adult‐Onset Dystonia‐Parkinsonism: Do Not Forget SERAC1
Movement Disorders Clinical Practice, EarlyView.
Giulia Scacciatella+15 more
wiley +1 more source